Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-Approved Early Alzheimer's Medications the Same Way They Do for All Other Diseases
October 11, 2024
October 11, 2024
WASHINGTON, Oct. 11 (TNSres) -- UsAgainstAlzheimer's, an organization that says it advocates for research that will speed treatments and drive changes that matter most to people living with Alzheimer's disease, issued the following news release:
* * *
American voters are willing to pay more to ensure access and want Congress to step in if Medicare continues restricting access to Alzheimer's treatments.
* * *
More than four in five voters (82%) . . .
* * *
American voters are willing to pay more to ensure access and want Congress to step in if Medicare continues restricting access to Alzheimer's treatments.
* * *
More than four in five voters (82%) . . .